Opinion

Video

Epidemiology and Impact of Hidradenitis Suppurativa

Author(s):

Iltefat Hamzavi, MD

An expert on hidradenitis suppurativa discusses the epidemiology of the disease and its profound impact on patients’ lives.

Video content above is prompted by the following questions:

  • What are some of the important epidemiological figures that are associated with hidradenitis suppurativa (HS) and how can clinicians incorporate these into their practices?
    • How can this disease negatively impact patients’ lives?
Related Videos
1 expert is featured in this series.
2 experts in this video
2 experts in this video
1 expert is featured in this series.
2 experts in this video
2 experts in this video
Related Content
Inpatient dermatology. | Image Credit: Seventyfour - stock.adobe.com
February 20th 2025

Redesigning Inpatient Dermatology to Address Costs, Improve Access

Cameron Santoro
The clinical and financial implications of inpatient dermatology were examined, highlighting the need for systemic changes to improve care, reduce costs, and address health equity for patients with skin diseases.
Atopic Dermatitis Itch. | Image Credit: Pormezz - stock.adobe.com
February 11th 2025

AI-Enabled Wearable Sensor Reduces Scratching in Atopic Dermatitis

Cameron Santoro
Patients with mild atopic dermatitis who reported nighttime scratching experienced relief when they used an artificial intelligence (AI)-powered wearable sensor that delivered haptic feedback on sleep behaviors.
Hidradenitis suppurativa. | Image Credit: Yurii Kibalnik - stock.adobe.com
January 28th 2025

Improving Hidradenitis Suppurativa Outcomes by Addressing Treatment Gaps

Cameron Santoro
Patients with hidradenitis suppurativa experience knowledge gaps on effective treatments and addressing these gaps could help prevent tissue damage among these patients.
Psoriasis. | Image Credit: IIIRusya - stock.adobe.com
January 27th 2025

Psoriasis Treatment Remains Effective, Safe After Switch From Ustekinumab to Biosimilar SB17

Cameron Santoro
Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching among patients with psoriasis for up to 52 weeks.
Acne. | Image Credit: frank29052515 - stock.adobe.com
January 22nd 2025

Dermocosmetics as Adjunctive Therapy Reduces Sensitivity and Improves Quality of Life in Acne

Marie Bosslett
Dermocosmetics alongside traditional acne treatments improved skin tolerance and reduced acne severity in patients, particularly those using retinoids, leading to enhanced quality of life.
Eczema. | Image Credit: InfiniteStudio - stock.adobe.com
January 14th 2025

Eczema Incidence Associated With Dietary Calcium Intake

Cameron Santoro
Increased eczema risks in certain populations were associated with moderately high calcium intake, although pregnant women were found to potentially benefit from higher calcium consumption.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo